Make your money go further for just 25p per day

Tiziana Life Sciences (AIM:TILS) excellent progress and exciting times ahead.

01/10/2015 · Tiziana Life Sciences PLC (TISL) 

Following the release of its interim results for the six months ended 30 June 2015, we are taking a look at progress from this interesting AIM biotech

This biotechnology company, founded in 2013, is focusing on the development of unique therapeutics to target cancer and autoimmune diseases. They have made a number of substantial progressions this year, giving them a positive outlook in targeting currently unmet medical needs.

One of the company’s research priorities is to develop a drug that can target advanced, or ‘metastatic’, breast cancer. This late-stage of the disease is responsible for a huge number of cancer deaths,…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Tiziana Life Sciences PLC

​August 2020: AIM arrivals, departures and IHT qualifiers

03/09/2020 · Company Insights

While London’s growth market failed to encourage any newcomers in August, AIM’s market value still leaped…


Tiziana Life Sciences (AIM:TILS) excellent progress and exciting times ahead.

01/10/2015 · Company Insights
Following the release of its interim results for the six months ended 30 June 2015, we…

More Company Insights

Elderly challenges | Demotion | Australian boost

21/11/2024 · Churchill China · CVS Group · Renold · Tracsis

Bonkers Bargains: poised to recover with a new CEO

20/11/2024 · James Cropper

Improving returns | Questionable business models

Sign-up to our free email updates

SIGN UP